iHA-100 exhibited a high efficacy whether administered during the early phase or late phase of H5N1 infection
Project/Area Number |
15H04739
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Virology
|
Research Institution | Tokyo Metropolitan Institute of Medical Science |
Principal Investigator |
KOHARA Michinori 公益財団法人東京都医学総合研究所, ゲノム医科学研究分野, 特任研究員 (10250218)
|
Co-Investigator(Kenkyū-buntansha) |
齊藤 誠 公益財団法人東京都医学総合研究所, ゲノム医科学研究分野, 研究員 (20433021)
徳永 優子 公益財団法人東京都医学総合研究所, ゲノム医科学研究分野, 研究員 (80555011)
|
Research Collaborator |
MUNAKTA Tsubasa
IMAI Yumiko
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥17,290,000 (Direct Cost: ¥13,300,000、Indirect Cost: ¥3,990,000)
Fiscal Year 2017: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2015: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
|
Keywords | ウイルス / 感染症 / 微生物 / 免疫学 / 特殊環状ペプチド / インフルエンザウイルス / 増殖抑制 |
Outline of Final Research Achievements |
Most anti-influenza drugs currently used, such as oseltamivir and zanamivir, inhibit the enzymatic activity of neuraminidase (NA). NA inhibitor-resistant viruses, however, have already been isolated among seasonal H1N1, pandemic (H1N1) 2009, and even highly pathogenic avian H5N1 viruses. These resistant viruses can only be controlled by a new antiviral with a mechanism of action that is totally different from NA inhibition. The recent development of the Random non-standard Peptides Integrated Discovery (RaPID) system enables the identification of high-affinity ligands for a protein of interest from easily prepared libraries consisting of over a trillion macrocyclic peptides. Here we report bi-functional, tropic macrocycles that bind the influenza viral envelope protein hemagglutinin and inhibit virus infection by blocking adsorption and fusion. They showed powerful efficacy in preventing severe pneumonia at later stages of infection in mouse and non-primate cynomolgus macaque models.
|
Academic Significance and Societal Importance of the Research Achievements |
次世代の抗体医薬として、従来抗体が結合し得ない抗原領域を認識することが可能な特殊環状ペプチドに着目した。H5N1インフルエンザウイルスHA蛋白質に対して結合する特殊環状ペプチドiHA100を創成し、マウスにおいてリレンザでは治療効果を示さない感染4日後および6日後からの投与においても治療効果を示した。さらに霊長類感染モデルとしてカニクイザルに高病原性H5N1インフルエンザ感染時の発症防御効果を検討したところ良好な結果が得られ、iHA100は新規インフルエンザ治療薬の可能性が示された。これらHAウイルス蛋白質の選択的な認識・排除機構を解明し、さらなる治療薬の最適化や治療法の確立につなげる。
|
Report
(4 results)
Research Products
(33 results)
-
-
-
-
-
-
[Journal Article] Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane2017
Author(s)
Ming Chen, Chie Aoki-Utsubo, Masanori Kameoka, Lin Deng, Yutaka Terada, Wataru Kamitani, Kei Sato, Yoshio Koyanagi, Makoto Hijikata, Keiko Shindo, Takeshi Noda, Michinori Kohara & Hak Hotta.
-
Journal Title
Scientific Reports
Volume: 7
Issue: 1
Pages: 15931-15931
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
[Journal Article] Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model2017
Author(s)
Yuko Tokunaga, Yosuke Osawa, Takahiro Ohtsuki, Yukiko Hayashi, Kenzaburo Yamaji, Daisuke Yamane, Mitsuko Hara, Keisuke Munekata, Kyoko Tsukiyama-Kohara, Tsunekazu Hishima, Soichi Kojima, Kiminori Kimura, and *Michinori Kohara
-
Journal Title
Scientific Reports
Volume: 7
Issue: 1
Pages: 325-325
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
[Journal Article] Sensitization with vaccinia virus harboring hemagglutinin recovers the immune potential against highly pathogenic H5N1 influenza virus in non-human primates2016
Author(s)
Fumihiko Yasui, Yasushi Itoh, Ai Ikejiri, Masahiro Kitabatake, Nobuo Sakaguchi, Keisuke Munekata, Shintaro Shichinohe, Yukiko Hayashi, Hirohito Ishigaki, Misako Nakayama, Yoshihiro Sakoda, Hiroshi Kida, Kazumasa Ogasawara, *Michinori Kohara
-
Journal Title
Scientific Reports
Volume: 6
Issue: 1
Pages: 37915-37915
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Novel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection2016
Author(s)
Yamamoto, N. Sato, Y. Munakata, T. Kakuni, M. Tateno, C. Sanada, T. Hirata, Y. Murakami, S. Tanaka, Y. Chayama, K. Hatakeyama, H. Hyodo, M. Harashima, H. Kohara, M.
-
Journal Title
Journal of hepatology
Volume: 64
Issue: 3
Pages: 547-455
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Amelioration of HCV liver fibrosis by selective inhibitor of Wnt/β-catenin/CBP signaling2016
Author(s)
Tokunaga Y., Osawa Y., Ohtsuki K., Yamaji K., Yamane D., Munekata K., Hara M., Kojima S., Kimura K., Kohara M.
Organizer
23rd International Symposium on Hepatitis C Virus and Related Viruses
Place of Presentation
Kyoto, Japan
Year and Date
2016-10-11
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-